改进抗菌药物耐药感染全球负担的估算方法
本文讨论量化抗菌药物耐药(AMR)细菌感染死亡负担所用方法的假设、特征、局限性和可比性,指出既往研究因方法、假设和数据不同导致全球负担估计不可比,分析框架不充分,结论是需要新的死亡估算方法,并需建立机制系统收集高质量临床数据集以支持准确评估负担和资源配置。
要点
- 既往AMR全球负担估计因方法、假设和数据不同而不可比。
- 现有分析框架不足以准确评估AMR感染死亡负担。
- 需建立机制系统收集高质量临床数据集并创新估算方法。
核心结论
- 既往研究估算的AMR全球负担因方法学、假设和数据不同而不可比,现有分析框架不充分。
- 需要新的方法来估算AMR感染导致的死亡。
研究设计与样本
- 本文为Personal View,讨论量化AMR细菌感染死亡负担所用方法的假设、特征、局限性和可比性。
主要发现
- 既往研究估算的全球AMR负担因方法学方法、假设和所用数据不同而不可比。
- 既往研究的分析框架不充分。
临床怎么用
- 需开发机制系统收集具有足够广度和质量的临床数据集,以支持准确评估负担。
- 需结合决策和资源配置来应对AMR干预措施。
局限性
- 本文未报告原始研究数据或系统评价结果,主要基于观点讨论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Estimating the global burden of disease from infections caused by pathogens that have acquired antimicrobial resistance (AMR) is essential for resource allocation and to inform AMR action plans at national and global levels. However, the scarcity of robust and accepted methods to determine burden is widely acknowledged. In this Personal View, we discuss the underlying assumptions, characteristics, limitations, and comparability of the approaches used to quantify mortality from AMR bacterial infections. We show that the global burdens of AMR estimated in previous studies are not comparable because of their different methodological approaches, assumptions, and data used to generate the estimates. The analytical frameworks from previous studies are inadequate, and we conclude that a new approach to the estimation of deaths caused by AMR infection is needed. The innovation of a new approach will require the development of mechanisms to systematically collect a clinical dataset of substantial breadth and quality to support the accurate assessment of burden, combined with decision-making and resource allocation for interventions against AMR. We define key actions required and call for innovative thinking and solutions to address these problems.
引用
- Limmathurotsakul D, Dunachie S, Fukuda K, et al. Improving the estimation of the global burden of antimicrobial resistant infections. Lancet Infect Dis. 2019. PMID: 31427174. doi:10.1016/S1473-3099(19)30276-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。